[HTML][HTML] The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics

M Naesens, C Roufosse, M Haas, C Lefaucheur… - American Journal of …, 2024 - Elsevier
Abstract The XVI-th Banff Meeting for Allograft Pathology was held at Banff, Alberta, Canada,
from 19th to 23rd September 2022, as a joint meeting with the Canadian Society of …

Pathophysiology of rejection in kidney transplantation

CL Tamargo, S Kant - Journal of Clinical Medicine, 2023 - mdpi.com
Kidney transplantation has been the optimal treatment for end-stage kidney disease for
almost 70 years, with increasing frequency over this period. Despite the prevalence of the …

Application of spatial-omics to the classification of kidney biopsy samples in transplantation

P Tasca, BM van den Berg, TJ Rabelink… - Nature Reviews …, 2024 - nature.com
Improvement of long-term outcomes through targeted treatment is a primary concern in
kidney transplant medicine. Currently, the validation of a rejection diagnosis and …

Electro‐Optical Multiclassification Platform for Minimizing Occasional Inaccuracy in Point‐of‐Care Biomarker Detection

C Dai, H ** review
T Silva-Sousa, JN Usuda, N Al-Arawe, F Frias… - Stem Cells, 2024 - academic.oup.com
Advanced bioinformatics analysis, such as systems biology (SysBio) and artificial
intelligence (AI) approaches, including machine learning (ML) and deep learning (DL), is …

[HTML][HTML] Banff Digital Pathology Working Group: image bank, artificial intelligence algorithm, and challenge trial developments

AB Farris, MP Alexander, UGJ Balis, L Barisoni, P Boor… - 2023 - frontierspartnerships.org
The Banff Digital Pathology Working Group (DPWG) was established with the goal to
establish a digital pathology repository; develop, validate, and share models for image …

[HTML][HTML] Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection

T de Nattes, J Beadle, C Roufosse - Current Opinion in …, 2024 - journals.lww.com
Access to biopsy-based transcriptomics will widen as regulatory approvals for platforms and
gene expression models develop. Clinicians need more evidence and guidance to inform …